EMEA (Europe, Middle East and Africa) Advanced Parenteral Drug Delivery Devices Market Report 2017


#1072335

118pages

QYResearch

$ 4000

In Stock

In this report, the EMEA Advanced Parenteral Drug Delivery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Advanced Parenteral Drug Delivery Devices for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Advanced Parenteral Drug Delivery Devices market competition by top manufacturers/players, with Advanced Parenteral Drug Delivery Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Advanced Parenteral Drug Delivery Devices for each application, including
Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Genito-Urinary Agents